Trial intelligence / Profile preview

Sched2: Single-dose Meningococcal C vaccine in UK infants

NCT00625677Phase 4Completed

Sponsor
UK Health Security Agency
Start
Feb 2008
Primary completion
Mar 2010
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Meningococcal group C polysaccharide conjugate vaccine in meningococcal infection, sponsored by UK Health Security Agency. Started Feb 2008; status: completed.

02

Drugs

Meningococcal group C polysaccharide conjugate vaccine
03

Conditions

meningococcal infection

Beyond the preview

Go deeper on NCT00625677.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00625677.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call